The Influence of Vasopressors on Free Flap Outcomes in Head and Neck Cancer Patients
Otolaryngology–Head and Neck Surgery · 2024-10 · 171 (4) · 1008-1016
DOI: 10.1002/ohn.924 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 05.08.2024. Verfasst von John Philip Le und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, The Pennsylvania State University, Hershey, Pennsylvania, USA. Hauptthemen laut MEDLINE: Free Tissue Flaps, Head and Neck Neoplasms, Plastic Surgery Procedures, Vasoconstrictor Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
To compare free flap outcomes between those who received and did not receive vasopressors (VPs) at the time of free flap reconstruction. Study Design This retrospective cohort study includes patients from January 2013 to January 2023.
Setting
This multicenter cohort study utilized data from the TriNetX Research Network which includes 80 health care organizations.
Methods
Head and neck cancer patients older than 18 years who underwent free flap reconstruction were separated into those who received or did not receive VPs on the day of surgery. The primary outcomes were flap failure defined by need for secondary free flap procedures, blood vessel repair, and other flap revision procedures.
Results
After propensity score matching, 7446 patients were analyzed. The VP group included 3723 patients (mean age [SD], 62.9 [11.4] years; 2511 males [67.4%]). The non‐VP group included 3723 patients (mean age [SD], 63.0 [11.2] years; 2479 males [66.6%]). Free flap outcomes were not statistically different between groups (secondary free flap: 166 [4.5%] VP vs 155 [4.2%] non‐VP, P = .04; vessel repair: 314 [8.4%] vs 319 [8.6%], P = .06; other flap revision procedures: 416 [11.2%] vs 449 [12.1%], P = .02). Bony flaps were found to have decreased rates of vessel repair in the VP group (47 [6.1%] vs 69 [9.0%], P = .003]. For secondary outcomes, pneumonia (173 [4.6%] vs 231 [6.2%], P = .0002), urinary tract infection (34 [1.0%] vs 59 [1.6%], P = .0007), and deep vein thrombosis (93 [2.5%] vs 122 [3.3%], P = .004) were significantly different.
Conclusion
VP use is not significantly associated with free flap complications. These results imply that VP use on the same day as surgery may be safe if clinically necessary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, The Pennsylvania State University, Hershey, Pennsylvania, USA.
- Department of Otolaryngology-Head and Neck Surgery, Penn State College of Medicine, Hershey, Pennsylvania, USA.
ORCID-Profile: Neerav Goyal
Förderung
- NCATS NIH HHS
Zitieren
APA
Le, J. P., Truong, N., Newland, M., Lorenz, F. J., & Goyal, N. (2024). The Influence of Vasopressors on Free Flap Outcomes in Head and Neck Cancer Patients. Otolaryngology–Head and Neck Surgery, 171(4), 1008-1016. https://doi.org/10.1002/ohn.924
Vancouver
Le JP, Truong N, Newland M, Lorenz FJ, Goyal N. The Influence of Vasopressors on Free Flap Outcomes in Head and Neck Cancer Patients. Otolaryngology–Head and Neck Surgery. 2024;171(4):1008-1016. doi:10.1002/ohn.924
BibTeX
@article{Le2024,
author = {Le, John Philip and Truong, Nguyen and Newland, Mary and Lorenz, F Jeffrey and Goyal, Neerav},
title = {The Influence of Vasopressors on Free Flap Outcomes in Head and Neck Cancer Patients},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
volume = {171},
number = {4},
pages = {1008--1016},
doi = {10.1002/ohn.924}
}
EUVIMED